420 related articles for article (PubMed ID: 26163953)
1. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
2. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
3. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
4. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for appendiceal and colorectal peritoneal metastases.
Enblad M; Graf W; Birgisson H
Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
[TBL] [Abstract][Full Text] [Related]
8. Management of colorectal cancer patients at high risk of peritoneal metastases.
Shariff U; Seretis C; Youssef H
J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study.
Mitry E; Guiu B; Cosconea S; Jooste V; Faivre J; Bouvier AM
Gut; 2010 Oct; 59(10):1383-8. PubMed ID: 20732912
[TBL] [Abstract][Full Text] [Related]
10. Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.
Klaver YL; Chua TC; Verwaal VJ; de Hingh IH; Morris DL
J Surg Oncol; 2013 May; 107(6):585-90. PubMed ID: 23280508
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
[TBL] [Abstract][Full Text] [Related]
12. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis from colorectal cancer.
Jayne DG; Fook S; Loi C; Seow-Choen F
Br J Surg; 2002 Dec; 89(12):1545-50. PubMed ID: 12445064
[TBL] [Abstract][Full Text] [Related]
16. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
[TBL] [Abstract][Full Text] [Related]
18. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.
Piso P; Bektas H; Werner U; Schlitt HJ; Kubicka S; Bornscheuer A; Manns M; Klempnauer J
Eur J Surg Oncol; 2001 Apr; 27(3):286-90. PubMed ID: 11373107
[TBL] [Abstract][Full Text] [Related]
19. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prognosis of synchronous colorectal carcinomatosis.
Goéré D; Allard MA; Honoré C; Dumont F; Elias D
Future Oncol; 2013 Apr; 9(4):541-9. PubMed ID: 23560376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]